LONDON STRATEGIC HEALTH AUTHORITY
4TH FLOOR, SOUTHSIDE, 105 VICTORIA STREET, LONDON, GREATER LONDON, SW1E 6QT See member list for this organisation
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 76478 | 91214 | 83.8% | |
| CKD 4 | 2008 | 91725 | 108622 | 84.4% | |
| CKD 5 | 2009 | 18533 | 20657 | 89.7% | |
| CKD 5 | 2010 | 11470 | 12403 | 92.5% | |
| CKD 5 | 2011 | 13429 | 14719 | 91.2% | |
| CKD 5 | 2012 | 14391 | 15915 | 90.4% |
